Form 4: Ionis Pharmaceuticals Executive Richard S. Geary Reports Stock Purchase

EVP Richard S. Geary of Ionis Pharmaceuticals reports purchasing common stock under the company's employee stock purchase plan.

Summary

• Richard S. Geary, EVP and Chief Development Officer of Ionis Pharmaceuticals, reported a transaction on August 30, 2024.
• Geary acquired 11 shares of Ionis Pharmaceuticals common stock at a price of $38.641 per share.
• The shares were purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan.
• Following the transaction, Geary beneficially owns 84,834 shares of Ionis Pharmaceuticals common stock.
• These shares may not be sold until February 28, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reports a routine transaction. The executive's purchase is a mildly positive signal, but not significantly impactful.

Positives

• The purchase of shares by an executive could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Executive stock purchases are common and are often viewed as a sign of confidence in the company's prospects. However, the impact on the stock price is usually minimal unless the purchase is substantial or part of a larger trend.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates